ADMA Biologics, Inc.

8-K Shareholder vote results Jun 2, 2026 10-Q Quarter ended 2026-03-31 May 6, 2026 8-K Results of operations (earnings release) May 6, 2026 8-K Other events May 4, 2026 8-K Regulation FD disclosure Mar 27, 2026 8-K Regulation FD disclosure; Other events Mar 2, 2026 10-K Fiscal year ended 2025-12-31 Feb 25, 2026 8-K Results of operations (earnings release); Director or officer change Feb 25, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Jan 12, 2026 10-Q Quarter ended 2025-09-30 Nov 5, 2025 8-K Results of operations (earnings release) Nov 5, 2025 10-Q Quarter ended 2025-06-30 Aug 6, 2025 8-K Entered a material agreement; Terminated a material agreement; Results of operations (earnings release); Took on a direct financial obligation Aug 6, 2025 8-K Shareholder vote results Jun 4, 2025 10-Q Quarter ended 2025-03-31 May 7, 2025 8-K Results of operations (earnings release); Other events May 7, 2025 8-K Other events Apr 28, 2025 10-K Fiscal year ended 2024-12-31 Mar 18, 2025 8-K Results of operations (earnings release) Mar 3, 2025 8-K Director or officer change Feb 21, 2025 8-K Regulation FD disclosure Jan 13, 2025 8-K Results of operations (earnings release) Jan 13, 2025 8-K Director or officer change Jan 2, 2025 8-K Other events Dec 20, 2024 8-K Director or officer change Nov 21, 2024 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Results of operations (earnings release) Nov 7, 2024 8-K Changed accountants Oct 31, 2024 8-K Regulation FD disclosure Oct 10, 2024 8-K Changed accountants Oct 9, 2024 8-K Other events Aug 14, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Results of operations (earnings release) Aug 8, 2024 8-K Director or officer change Jul 26, 2024 8-K Amended charter or bylaws Jun 28, 2024 8-K Shareholder vote results Jun 4, 2024 8-K Regulation FD disclosure May 17, 2024 10-Q Quarter ended 2024-03-31 May 9, 2024 8-K Results of operations (earnings release) May 9, 2024 8-K Director or officer change Apr 2, 2024